bromoform
{{Chembox
| Watchedfields = changed
| verifiedrevid = 443669482
| ImageFileL1 = Bromoform-2D-skeletal.png
| ImageFileL1_Ref = {{chemboximage|correct|??}}
| ImageNameL1 = Skeletal formula of bromoform
| ImageFileR1 = Natta projection of bromoform.svg
| ImageFileR1_Ref = {{chemboximage|correct|??}}
| ImageNameR1 = Stereo, skeletal formula of bromoform with the explicit hydrogen added
| ImageFile2 = Bromoform-3D-vdW.png
| ImageFile2_Ref = {{chemboximage|correct|??}}
| ImageSize2 = 100
| ImageName2 = Spacefill model of bromoform
| ImageFile3 = Bromoformbottle.jpg
| ImageCaption3 = A bottle of bromoform with some in the adjacent beaker
| PIN = Tribromomethane{{cite book | title = Nomenclature of Organic Chemistry : IUPAC Recommendations and Preferred Names 2013 (Blue Book) | publisher = The Royal Society of Chemistry | date = 2014 | location = Cambridge | page = 661 | doi = 10.1039/9781849733069-FP001 | isbn = 978-0-85404-182-4 | quote = The retained names 'bromoform' for HCBr3, 'chloroform' for HCCl3, and 'iodoform' for HCI3 are acceptable in general nomenclature. Preferred IUPAC names are substitutive names.}}
| OtherNames = {{Unbulleted list|Bromoform|Methenyl tribromide{{Citation needed|date=June 2012}}|Methyl tribromide|
}}
| Section1 = {{Chembox Identifiers
| Abbreviations = {{Unbulleted list|R-20B3{{Citation needed|date=June 2012}}|UN 2515
}}
| CASNo = 75-25-2
| CASNo_Ref = {{cascite|correct|CAS}}
| PubChem = 5558
| ChemSpiderID = 13838404
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| UNII = TUT9J99IMU
| UNII_Ref = {{fdacite|correct|FDA}}
| EINECS = 200-854-6
| UNNumber = 2515
| DrugBank = DB03054
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| KEGG = C14707
| KEGG_Ref = {{keggcite|correct|kegg}}
| MeSHName = bromoform
| ChEBI = 38682
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 345248
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| RTECS = PB5600000
| Beilstein = 1731048
| Gmelin = 49500
| SMILES = BrC(Br)Br
| StdInChI = 1S/CHBr3/c2-1(3)4/h1H
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = DIKBFYAXUHHXCS-UHFFFAOYSA-N
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
}}
| Section2 = {{Chembox Properties
| C=1 | H=1 | Br=3
| Appearance = Colorless liquid
| Density = 2.89 g/cm3
| MeltingPtK = 281.84{{cite book |last1=Rumble |first1=John |title=CRC Handbook of Chemistry and Physics |date=18 June 2018 |publisher=CRC Press |isbn=9781138561632 |pages=3–50}}
| BoilingPtK = 422.55
| Solubility = 3.2 g L−1 (at 30 °C)
| LogP = 2.435
| VaporPressure = 670 Pa (at 20.0 °C)
| HenryConstant = 17 μmol Pa−1 kg−1
| RefractIndex = 1.595
| pKa = 13.7
| MagSus = −82.60·10−6 cm3/mol
}}
| Section3 = {{Chembox Thermochemistry
| DeltaHf = 6.1–12.7 kJ mol−1
| DeltaHc = −549.1–−542.5 kJ mol−1
| HeatCapacity = 130.5 J K−1 mol−1
}}
| Section4 = {{Chembox Hazards
| GHSPictograms = {{GHS skull and crossbones}} {{GHS environment}}
| GHSSignalWord = DANGER
| HPhrases = {{H-phrases|302|315|319|331|411}}
| PPhrases = {{P-phrases|261|273|305+351+338|311}}
| NFPA-H = 3
| NFPA-F = 0
| NFPA-R = 0
| LD50 = 933.0 mg kg−1 (oral, rat)
| PEL = TWA 0.5 ppm (5 mg/m3) [skin]{{PGCH|0066}}
| REL = TWA 0.5 ppm (5 mg/m3) [skin]
| LC50 = 1151 ppm (mammal){{IDLH|75252|Bromoform}}
| LCLo = 4282 ppm (rat, 4 hr)
7000 ppm (dog, 1 hr)
| LDLo = 1400 mg/kg (mouse, oral)
1147 mg/kg (rat, oral)
}}
| Section5 = {{Chembox Related
| OtherFunction_label = alkanes
| OtherFunction = {{Unbulleted list|Dibromomethane|Tetrabromomethane|1,1-Dibromoethane|1,2-Dibromoethane|Tetrabromoethane}}
}}
}}
Bromoform is an organic compound with the chemical formula {{chem2|CHBr3}}. It is a colorless liquid at room temperature, with a high refractive index and a very high density. Its sweet odor is similar to that of chloroform. It is one of the four haloforms, the others being fluoroform, chloroform, and iodoform. It is a brominated organic solvent. Currently its main use is as a laboratory reagent. It is very slightly soluble in water (one part bromoform in 800 parts water) and is miscible with alcohol, benzene, chloroform, ether, petroleum ether, acetone and oils.
Structure
The molecule adopts tetrahedral molecular geometry with C3v symmetry.
Synthesis
Bromoform was discovered in 1832 by Löwig who distilled a mixture of bromal and potassium hydroxide, as analogous to preparation of chloroform from chloral.George M. Beringer, BROMOFORM (1891) in American Journal of Pharmacy vol 63
[https://archive.org/details/americanjour634211891phil/page/82/mode/1up p. 82]
Bromoform can be prepared by the haloform reaction using acetone and sodium hypobromite, by the electrolysis of potassium bromide in ethanol, or by treating chloroform with aluminium bromide.
Uses
Only small quantities of bromoform are currently produced industrially in the United States. In the past, it was used as a solvent, sedative and flame retardant, but now it is mainly used as a laboratory reagent, for example as an extraction solvent.
Bromoform's high density makes it useful for separation of minerals by density. When two samples are mixed with bromoform and then allowed to settle, the top layer will contain minerals less dense than bromoform, and the bottom layer will contain denser minerals. Slightly less dense minerals can be separated in the same way by mixing the bromoform with a small amount of a less dense and miscible solvent.
Bromoform is known as an inhibitor of methanogenesis and is a common component of seaweed. Following research by CSIRO and its spin-off FutureFeed, several companies are now growing seaweed, in particular from the genus Asparagopsis, to use as a feed additive for livestock to reduce methane emissions from ruminants.{{Cite web|title=Is seaweed the solution to agriculture's methane problem?|url=https://phyconomy.net/seaweed/applications/livestock-methane-reduction/|access-date=2020-11-13|website=Phyconomy|language=en-US}}
Occurrence
Bromoform is very commonly made by phytoplankton and seaweeds in the ocean. Bromoform is the most abundant halogenated compound in Asparagopsis.{{cite journal |last1=Ponte |first1=José M. S. |last2=Seca |first2=Ana M. L. |last3=Barreto |first3=Maria Carmo |title=Asparagopsis Genus: What We Really Know About Its Biological Activities and Chemical Composition |journal=Molecules |date=9 March 2022 |volume=27 |issue=6 |pages=1787 |doi=10.3390/molecules27061787|doi-access=free |pmid=35335151 |hdl=10400.3/6452 |hdl-access=free }}
Environment and toxicology
Natural production of bromoform by phytoplankton and seaweeds in the ocean is thought to be its predominant source in the environment.Palmer C J and Reason C J (2009), Relationships of surface bromoform concentrations with mixed layer depth and salinity in the tropical oceans (2009), Global Biogeochemical Cycles, 23, GB2014. However, locally significant amounts of bromoform enter the environment formed as disinfection byproducts known as trihalomethanes when chlorine is added to drinking water to kill bacteria. It is somewhat soluble in water and readily evaporates into the air. Bromoform is the main trihalomethane produced in beachfront salt water swimming pools with concentrations as high as 1.2 ppm (parts per million). Concentrations in freshwater pools are 1000 times lower.Beech AJ et al (1980) Nitrates, Chlorates and Trihalomethanes in Swimming Pool Water. Am J Public Health, 70(1), 79-82 Occupational skin exposure limits are set at 0.5 ppm.[https://www.cdc.gov/niosh/npg/npgd0066.html CDC - NIOSH Pocket Guide to Chemical Hazards]
The substance may be hazardous to the environment, and special attention should be given to aquatic organisms. Its volatility and environmental persistence makes bromoform's release, either as liquid or vapor, strongly inadvisable.
Bromoform can be absorbed into the body by inhalation and through the skin. The substance is irritating to the respiratory tract, the eyes, and the skin, and may cause effects on the central nervous system and liver, resulting in impaired functions. Its LD50 is 7.2 mmol/kg in mice, or 1.8 g/kg. The International Agency for Research on Cancer (IARC) concluded that bromoform is not classifiable as to human carcinogenicity. The EPA classified bromoform as a probable human carcinogen.IARC - https://monographs.iarc.fr/wp-content/uploads/2018/06/mono52-10.pdfATSDR - https://www.atsdr.cdc.gov/toxfaqs/tf.asp?id=712&tid=128
References
- {{cite journal |author1=Betterton E. A. |author2=Arnold R. G. |author3=Kuhler R. J. |author4=Santo G. A. |date=June 2005 | title = Reductive dehalogenation of bromoform in aqueous solution | journal = Environ. Health Perspect. | volume = 103 |issue=Suppl 5 | pages = 89–91(3) | pmid = 8565919 | doi = 10.2307/3432487| pmc = 1519304 | publisher = Brogan & | jstor = 3432487 }} [http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1519304&blobtype=pdf PDF]
- U.S. Department of Health and Human Services. Toxicological Profile for Bromoform and Dibromochloromethane [https://web.archive.org/web/20080515132119/http://www.atsdr.cdc.gov/toxprofiles/tp130.html]. August 2005.
{{Reflist}}
External links
- {{ICSC|0108|01}}
- {{PGCH|0066}}
- [http://www.chemicalland21.com/industrialchem/solalc/BROMOFORM.htm Entry at chemicalland21.com]
- [https://www.atsdr.cdc.gov/toxprofiles/tp130.pdf Toxicological profile for bromoform and dibromochlormethane]
- [https://web.archive.org/web/20060929185136/http://cira.ornl.gov/documents/BROMOFRM.pdf Toxicity summary]
- IARC Summaries & Evaluations: [http://www.inchem.org/documents/iarc/vol52/05-bromoform.html Vol. 62 (1991)], [http://www.inchem.org/documents/iarc/vol71/069-bromoform.html Vol. 71 (1999)]
- [http://chemsub.online.fr/name/bromoform.html ChemSub Online: Bromoform]
{{Halomethanes}}
{{Authority control}}
Category:IARC Group 3 carcinogens
Category:Halogen-containing natural products
Category:Bromine-containing natural products